Metacrine Inc

Company Profile

Metacrine Inc had its IPO on 2020-09-16 under the ticker symbol MTCR.

The company operates in the sector and industry. Metacrine Inc has a staff strength of 10 employees.

Stock update

Shares of Metacrine Inc opened at $0 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0 - $0, and closed at $0.

This is a 0% increase from the previous day's closing price.

A total volume of 83,889 shares were traded at the close of the day’s session.

In the last one week, shares of Metacrine Inc have slipped by -99.76%.

Metacrine Inc's Key Ratios

Metacrine Inc has a market cap of $25.48 million, indicating a price to book ratio of 0.4043 and a price to sales ratio of 0.

In the last 12-months Metacrine Inc’s revenue was $2.18 million with a gross profit of $-45474000 and an EBITDA of $-35998000. The EBITDA ratio measures Metacrine Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Metacrine Inc’s operating margin was 0% while its return on assets stood at -36.86% with a return of equity of -90.72%.

In Q3, Metacrine Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Metacrine Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-1.03 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Metacrine Inc’s profitability.

Metacrine Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0.6705. Its price to sales ratio in the trailing 12-months stood at 0.

Metacrine Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$55.04 million

Total Liabilities

$4.53 million

Operating Cash Flow

$10.20 million

Capital Expenditure

$0

Dividend Payout Ratio

0%

Metacrine Inc ended 2024 with $55.04 million in total assets and $0 in total liabilities. Its intangible assets were valued at $55.04 million while shareholder equity stood at $37.07 million.

Metacrine Inc ended 2024 with $0 in deferred long-term liabilities, $4.53 million in other current liabilities, 4000.00 in common stock, $-207616000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $52.75 million and cash and short-term investments were $52.75 million. The company’s total short-term debt was $1,208,000 while long-term debt stood at $12.58 million.

Metacrine Inc’s total current assets stands at $55.04 million while long-term investments were $0 and short-term investments were $0.00. Its net receivables were $55000.00 compared to accounts payable of $691000.00 and inventory worth $0.

In 2024, Metacrine Inc's operating cash flow was $10.20 million while its capital expenditure stood at $0.

Comparatively, Metacrine Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0

52-Week High

$0.585

52-Week Low

$0.0014

Analyst Target Price

$0.5

Metacrine Inc stock is currently trading at $0 per share. It touched a 52-week high of $0.585 and a 52-week low of $0.585. Analysts tracking the stock have a 12-month average target price of $0.5.

Its 50-day moving average was $0.53 and 200-day moving average was $0.48 The short ratio stood at 0.21 indicating a short percent outstanding of 0%.

Around 1478.1% of the company’s stock are held by insiders while 3713% are held by institutions.